We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Video Expert Opinion
Round Table Discussions
Sign in
Join now
featured
Published in Urology and
1 other channel

Journal Scan / Research · September 30, 2014

Influence of Prior Abiraterone on Clinical Activity of Docetaxel in Metastatic Castration-Resistant Prostate Cancer

European Urology

 

Save Recommend
Share

Additional Info

Disclosure statements are available on the authors' profiles:

Gautam Jayram MD

European Urology
The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men With Metastatic Castration-Resistant Prostate Cancer
Eur Urol 2014 Oct 01;66(4)646-652, MT Schweizer, XC Zhou, H Wang, S Bassi, MA Carducci, MA Eisenberger, ES Antonarakis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated